announcements

A grand opportunity presents itself...

 

Lung cancer remains the No. 1 cancer-killer of Americans. As part of its mission, the IASLC strives to use all available means to eliminate lung cancer as a health threat for the individual patient and throughout the world. Recently, IASLC leaders were awarded a $5.2 million Grand Opportunities Grant by the American Recovery and Reinvestment Act (ARRA) and the National Cancer Institute to hold free genetic tumor screening for lung cancer patients at 13 sites across the country. Known as the Lung Cancer Mutation Consortium Protocol, the goal of the project is to assess mutations in lung adenocarcinoma tumors where oral therapies are specific, more effective and less toxic. The consortium will be led by Dr. Paul A. Bunn, Jr., executive director of the IASLC and University of Colorado Cancer Center founding director. Dr. Wilbur Franklin, professor of pathology at the University of Colorado Denver and UCCC member, is the principal investigator.  Patients who wish to participate in the trial should contact Mary Jackson at 303-724-1650

 

Fellowship Awards

IASLC Lung Cancer Fellowship Award/Young Investigators Award - 2 years duration

IASLC/PCF Prevent Cancer Foundation Fellowship Award - 2 years duration

See Guidelines for Fellowships

[Top of Page]

Career Opportunities in Thoracic Oncology

If you have a position to list on this website, please email your request with all of the pertinent information.

 

[Top of Page]